跳至主要内容
临床试验/NCT00452829
NCT00452829已完成1 期

Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study)

Institute of Child Health1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
100
试验地点
1

研究概览

简要总结

The aim of the study is to develop a randomised, double blind clinical trial to compare (i) folic acid plus inositol, with (ii) folic acid plus placebo, for prevention of recurrent neural tube defects.

详细描述

Women were eligible to join the PONTI pilot study if they had a history of previous NTD-affected pregnancy, were planning to become pregnant again, and were prepared to be randomised to one of the two study arms. Both study and control groups received 5 mg folic acid (the standard UK supplement for pregnancies at high risk of NTD); the study group additionally received 1 g inositol, whereas the control group was prescribed a placebo instead of inositol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Study Group

Experimental

5 mg folic acid (the standard UK supplement for pregnancies at high risk of NTD) and 1 g inositol,

干预措施: Folic Acid and inositol (Drug)

Control Group

Placebo Comparator

5 mg folic acid (the standard UK supplement for pregnancies at high risk of NTD)and 1 g placebo

干预措施: Folic acid and placebo (Drug)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验